We are live on
!
Find out more
CFO
Callan Family Office Portfolio holdings
AUM
$4.41B
1-Year Est. Return
26.21%
This Fund
S&P 500
This Quarter
Est. Return
+6.16%
1 Year Est. Return
+26.21%
3 Year Est. Return
+68.96%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$412M
AUM Growth
+$102M
(+33%)
Cap. Flow
+$85.1M
Cap. Flow
% of AUM
20.66%
Top 10 Holdings %
Top 10 Hldgs %
57.33%
Holding
160
New
58
Increased
65
Reduced
17
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$15.7M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$10.1M |
| 3 |
Wells Fargo
WFC
|
+$5.54M |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$5.38M |
| 5 |
Microsoft
MSFT
|
+$3.78M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Large-Cap ETF
VV
|
+$15M |
| 2 |
Caterpillar
CAT
|
+$3.39M |
| 3 |
iShares Russell 1000 Value ETF
IWD
|
+$2.87M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$891K |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$509K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.19% |
| 2 | Financials | 4.4% |
| 3 | Healthcare | 3.71% |
| 4 | Industrials | 2.12% |
| 5 | Communication Services | 1.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
iShares Core MSCI Emerging Markets ETF
IEMG
$156B
| $1.18M | 0.29% |
24,274
-10,375
| -30% | -$509K |
|
52
Goldman Sachs
GS
$303B
| $1.18M | 0.29% |
+3,605
| New | +$1.25M |
|
53
iShares Russell Mid-Cap Value ETF
IWS
$15.9B
| $1.18M | 0.29% |
11,091
+5,009
| +82% | +$547K |
|
54
Gilead Sciences
GILD
$165B
| $1.14M | 0.28% |
+13,778
| New | +$1.14M |
|
55
Chevron
CVX
$366B
| $1.13M | 0.27% |
6,915
+4,005
| +138% | +$671K |
|
56
abrdn Bloomberg All Commodity Strategy K-1 Free ETF
BCI
$3B
| $1.13M | 0.27% |
54,242
| – | – |
|
57
Johnson Controls International
JCI
$92.2B
| $1.07M | 0.26% |
+17,745
| New | +$1.14M |
|
58
First Trust NASDAQ Cybersecurity ETF
CIBR
$15.3B
| $1.05M | 0.25% |
24,500
| – | – |
|
59
iShares S&P 100 ETF
OEF
$20.5B
| $1.03M | 0.25% |
+5,520
| New | +$990K |
|
60
Home Depot
HD
$355B
| $1.01M | 0.24% |
3,417
+2,063
| +152% | +$633K |
|
61
Charter Communications
CHTR
$18.2B
| $986K | 0.24% |
+2,756
| New | +$1.03M |
|
62
PepsiCo
PEP
$190B
| $964K | 0.23% |
5,289
+1,974
| +60% | +$345K |
|
63
CVS Health
CVS
$122B
| $956K | 0.23% |
12,871
+10,701
| +493% | +$897K |
|
64
GSK
GSK
$106B
| $922K | 0.22% |
+25,900
| New | +$906K |
|
65
Johnson & Johnson
JNJ
$625B
| $916K | 0.22% |
5,909
+1,495
| +34% | +$241K |
|
66
GE Aerospace
GE
$384B
| $892K | 0.22% |
+11,694
| New | +$782K |
|
67
Eaton
ETN
$174B
| $887K | 0.22% |
5,176
-97
| -2% | -$16.1K |
|
|
BNY
68
Bank of New York Mellon
BNY
$107B
| $884K | 0.21% |
+19,447
| New | +$943K |
|
69
Novartis
NVS
$297B
| $884K | 0.21% |
+9,605
| New | +$839K |
|
70
Procter & Gamble
PG
$339B
| $862K | 0.21% |
5,794
+1,133
| +24% | +$162K |
|
71
Target
TGT
$68B
| $850K | 0.21% |
5,130
-28
| -0.5% | -$4.6K |
|
72
MetLife
MET
$62.1B
| $843K | 0.2% |
+14,542
| New | +$981K |
|
73
Merck
MRK
$318B
| $811K | 0.2% |
7,619
+2,532
| +50% | +$273K |
|
74
ConocoPhillips
COP
$141B
| $804K | 0.2% |
+8,104
| New | +$887K |
|
75
Booking.com
BKNG
$161B
| $748K | 0.18% |
+7,050
| New | +$686K |
|
Similar funds
FIS
CAU
EQF
SFM
EC
IC
GIBU
Callan Family Office's Q1 2023 Portfolio in Review
As of Q1 2023, Callan Family Office held 160 positions worth $412M, up 33% from $310M the previous quarter. Its ten largest holdings account for 57% of the portfolio.
Callan Family Office deployed $85.1M of net new capital in Q1 2023, opening 58 new positions and adding to 65 existing holdings. Its largest new stake was Wells Fargo: 127,067 shares worth $4.75M.
By sector, the portfolio is most concentrated in Technology at 5.2% of assets, up from 1.8% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Caterpillar, an estimated $3.39M trimmed.
- Callan Family Office's largest Q1 2023 buy was Wells Fargo: 127,067 shares worth $4.75M.
- Callan Family Office added most to iShares MSCI EAFE ETF in Q1 2023, an estimated $15.7M increase.
- Callan Family Office's biggest Q1 2023 reduction was Caterpillar, cutting an estimated $3.39M.
- Callan Family Office fully exited Vanguard Morningstar Large-Cap ETF in Q1 2023, selling an estimated $15M.
- Callan Family Office's ten largest holdings make up 57% of its $412M portfolio in Q1 2023.
- Callan Family Office opened 58 new positions and closed 7 in Q1 2023.
- Callan Family Office's portfolio value rose 33% quarter-over-quarter to $412M.
Based on Callan Family Office's 13F filing for Q1 2023, filed 12 May 2023.